Clinical Trials Logo

Clinical Trial Summary

To explore the effect and prognosis of endovascular interventional therapy in high-risk patients with aortic arch dissection and aneurysm


Clinical Trial Description

The WeFlow-Tribranch Aortic Arch Stent Graft System first in man study is a prospective, multi-center, single arm trial, which will enroll a total of 20 patients. The goal of this study is to evaluate the safety and efficacy of WeFlow-Tribranch Aortic Arch Stent Graft System in the treatment of patients with aortic arch dissection and aneurysm. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05754541
Study type Interventional
Source Hangzhou Endonom Medtech Co., Ltd.
Contact Wei Guo
Phone 13611129129
Email Pla301dml@vip.sina.com
Status Recruiting
Phase N/A
Start date November 10, 2022
Completion date December 31, 2025

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05434481 - MITAORTA - Role of Mitochondrial Dynamic in Aneurysm and Dissection of Ascending Thoracic Aorta N/A
Active, not recruiting NCT03861741 - A Study to Evaluate the Feasibility of Screening Relatives of Patients Affected by Non-Syndromic Thoracic Aortic Diseases N/A
Not yet recruiting NCT04431336 - Young Patient With Aortic Dissection or Aneurysm: A Prospective Observational Cohort Study
Recruiting NCT06336213 - Antibacterial Tactics Based on Presepsin Level in Thoracic Aorta Surgery Patients N/A